Peter McWilliams is the founder of Glycomine. Glycomine has raised $45M in total funding. Latest round: Series B. Based in San Carlos, CA.
Peter McWilliams is the CEO of Glycomine, Inc., a biotechnology company focused on developing therapies for rare diseases. He transitioned to the full-time CEO role in connection with a $33 million Series B financing round in 2019. Glycomine's work includes advancing a substrate replacement therapy for PMM2-CDG (CDG-1a).
Full founder directory · Investor directory · Company funding database · Fundraising library